These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 357975)
1. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med; 1978 Oct; 299(17):953-5. PubMed ID: 357975 [No Abstract] [Full Text] [Related]
2. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues. Gent M; Barnett HJ; Sackett DL; Taylor DW Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357 [TBL] [Abstract][Full Text] [Related]
3. Randomized trial of therapy with platelet antiaggregants for threatened stroke. The Canadian Cooperative Stroke Study Group Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457 [No Abstract] [Full Text] [Related]
5. Aspirin to prevent a stroke? N Z Med J; 1978 Oct; 88(621):286-7. PubMed ID: 364347 [No Abstract] [Full Text] [Related]
6. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease. Friedman LM Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355 [TBL] [Abstract][Full Text] [Related]
7. Does aspirin prevent stroke? Mitchell JR Practitioner; 1979 Nov; 223(1337):668-72. PubMed ID: 394138 [No Abstract] [Full Text] [Related]
8. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke. Whisnant JP Am Heart J; 1980 Jan; 99(1):129-30. PubMed ID: 6985763 [No Abstract] [Full Text] [Related]
9. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. Canadian Cooperative Study Group N Engl J Med; 1978 Jul; 299(2):53-9. PubMed ID: 351394 [TBL] [Abstract][Full Text] [Related]
10. Prevention of stroke. Barnett HJ Int Anesthesiol Clin; 1984; 22(3):11-29. PubMed ID: 6384054 [No Abstract] [Full Text] [Related]
11. The Canadian cooperative study of platelet suppressant therapy in threatened stroke. Gent M Thromb Haemost; 1979 Feb; 41(1):163-70. PubMed ID: 483230 [No Abstract] [Full Text] [Related]
12. Trials of antiplatelet drugs: some methodological considerations. Armitage P Rev Epidemiol Sante Publique; 1979 Sep; 27(2):87-90. PubMed ID: 538303 [No Abstract] [Full Text] [Related]
13. Stroke prevention. S Afr Med J; 1978 Aug; 54(8):300. PubMed ID: 715615 [No Abstract] [Full Text] [Related]
14. [Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants]. Guiraud-Chaumeil B Presse Med; 1983 Dec; 12(48):3045-8. PubMed ID: 6228912 [No Abstract] [Full Text] [Related]
15. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention. Polli EE; Cortellaro M Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788 [No Abstract] [Full Text] [Related]
18. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes]. Bousser MG Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464 [No Abstract] [Full Text] [Related]